ORIC Pharmaceuticals, South San Francisco, CA, Onsite
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by _Overcoming Resistance In Cancer._ ORIC’s clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to [www.oricpharma.com](https://www.globenewswire.com/Tracker?data=eooMg_hERq6eFqGDRd-83hX-Mst0lcYc1svXH2ckLupnk6vtLoglOqJIgTs8MHwL0QPw6PkR6mgqYlLD18BF8zpyJwfylpWEj3N581NQgB8SrNpUUBfl5o7bjLxRUCwPQl1WKkB-WM-PUt0weune6_p99pUrdMXnKUev5RBNt5SlNL-MjnKFBmhXLCjRuTE3lzMIJmdSFjkyo7oEeeNBI_CpUw2XrXA4Z79hhEKc-Zof-JpmV7cL1VcBVbcZid2daMWiR1QiUjFjJBu5_xxaWQ==), and follow us on [X](https://www.globenewswire.com/Tracker?data=LkLeYYGZ1oQEt1na2bEHz1i_5V_ANCJV914tcF8xKb3uJEMI74JlihUQrtDMbODZMg6o4Ve4Cm8gSTseAwt9W7qqiwhvJPqwuF_fm3eVQPZEsjSa91YvZN_vzIEsUUAISFW-w3ZrVKPJVA-7ENI28JS6V7MVNBwYkoML_tPwfN355GPp9EOqyMvF4XrmA-V-xndBLTfTnEP0EIZXNpQk8g==) or [LinkedIn](https://www.globenewswire.com/Tracker?data=GbNlnIwHngnq11YKEizZhZ60FnTxvbb3nyDpv4jAYm8kWEtHRz1Px7GwUkt0J_op_ePBIf-chEsXxfFk-dOJV0C42HhN_Ut9Anph0woHJkFnQsMAfVif4MM84lNccWH8lqQfJdoYm5Ib0apfW1RXUvbnu2rLEMVmFZFRBT6YinCsWzbyJviQuar2jyK3Ym6JvYuLW4DE-OXIUYAIhYYo8ZNZ042Ra2D86u8qkOZhwgw8md7M3r6HW4klqCbXs_ZzFlMUOmPBS4uLBi3ba7Fy7g==).
This role requires a leader with strong business acumen to define and execute business processes that drive complex programs through global registration and commercialization. This role will play a pivotal part in bringing innovative therapies to patients by ensuring that CMC development, manufacturing, and commercialization are executed with excellence, speed, and financial discipline.
This individual will also oversee project management including timelines, budgets, invoices, reports and documentation, and may assist with regulatory filings. This position reports to the Chief Technical Officer and is responsible for the following:
The anticipated salary range for Associate Director level candidates who will work on-site at our South San Francisco location is between $210,000-$260,000. The final wage offered to a successful candidate will be dependent on several factors that may include, title, type and length of experience within the role, type and length of experience within the industry, education, geography, and other job-related factors. This position is not eligible for H-1B visa sponsorship.
ORIC Pharmaceuticals, Inc. is an equal opportunity employer. ORIC does not discriminate based on race, color, religion, gender, sexual orientation, gender identity, age, national origin, disability status, protected veteran status, or any other legally protected characteristics.
By clicking the link above or any third-party link within this posting, you are leaving this site and going to a third-party website where the third-party website's terms and privacy policy apply
ORIC Pharmaceuticals is a clinical-stage biopharma company developing therapies to overcome cancer resistance and improve patient lives.
View company profile →